Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

August-14-06

Barr Laboratories Intends to Resubmit EC Application

Barr Laboratories has announced that it will incorporate an 18 and older age restriction into its application for emergency contraception (EC) to be made available over-the-counter to accommodate acting FDA Commissioner Andrew von Eschenbach’s request that the age limit be raised from 16.

In May 2004, Barr received a "not approvable" letter in response to its original application for EC to be available over-the-counter because of insufficient information on its use for girls younger than 16. Barr then resubmitted an application for over-the-counter access for women and girls over the age of 16, yet was denied again. In a recent letter to Barr subsidiary Duramed Research, von Eschenbach wrote that 18 is the "appropriate age" for women to access EC without a prescription, Reuters reports.

Barr CEO Bruce Downey told Reuters that he disagrees with the age restriction, noting that it will make it difficult for some women who could face an unintended pregnancy if they cannot access EC over-the-counter: "That need doesn’t discriminate on the basis of age. If you're 17 and need [EC], you need it just as quickly as someone who is 31 and needs it." Over-the-counter sales of EC have great importance because the drug is most effective taken immediately following unprotected sex, but is effective up until 120 hours.

The method by which an age restriction for over-the-counter sales would be enforced has yet to be determined. von Eschenbach requested a description of Barr’s plans to enforce the 18 and over age restriction in his letter to Duramed, writing "If after our discussion we conclude [your] program isn’t sufficiently rigorous… Plan B will remain [prescription]-only for women of all ages." Downey responded, however, that Barr cannot be held accountable for pharmacists that do not obey the restrictions.

If the FDA approves Barr's new application, the drug would be available over-the-counter within a few months.

TAKE ACTION Tell the FDA that you support over-the-counter access to emergency contraception!

DONATE to support the Feminist Majority Foundation's Campus Program, which is working to increase access to EC on college campuses

Media Resources: Reuters 8/9/2006; Kaiser Daily Women’s Health Policy 10/10/2006; Feminist Daily Newswire 10/9/2006


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

12/22/2014 McDonald's Responsible for 86 Cases of Misconduct Against Workers - The National Labor Relations Board (NLRB) ruled Friday that the McDonald's corporation is responsible for several dozen complaints of retaliatory conduct against workers fighting for job improvements. Since November 2012, 291 charges have been filed against McDonald's franchisees. . . .
 
12/22/2014 President Obama Calls Only On Women During 2014's Last Press Conference - In case you missed it, President Obama on Friday held his last press conference of 2014 - and when it was time for questions, he only called on women. The press corps has long been dominated by men, and Helen Thomas became the first female reporter to cover the White House in 1960. It was not the first time President Obama took questions from only women. . . .
 
12/19/2014 Woman on Life Support Revives Ireland Abortion Debate - Debate surrounding Ireland's ban on abortion has come up again following a current case involving a woman who is being kept on life support because she is pregnant. The woman's family wants her to be taken off life support, but doctors refuse because Irish law says they must do what they can to protect the 16-week-old fetus. . . .